End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
185,900 KRW | +3.28% | -3.73% | +88.73% |
2023 | Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA | CI |
2023 | ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
ETFs positioned on ALTEOGEN Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.64% | 2 M€ | -14.14% | ||
0.02% | 4 M€ | -4.41% | - | |
0.01% | 7 M€ | +5.36% | - | |
0.00% | 112 M€ | +4.61% | - | |
0.00% | 45 M€ | -.--% | - | |
0.00% | 34 M€ | +7.50% | - | |
0.00% | 306 M€ | +5.07% | - | |
0.00% | 39 M€ | +5.00% | - | |
0.00% | 34 M€ | +3.86% | - | |
0.00% | 7 M€ | +0.11% | - |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+88.73% | 7.14B | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B |
- Stock Market
- Equities
- A196170 Stock
- Funds and ETFs ALTEOGEN Inc.